CompletedPhase 2

Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts

Egypt64 participantsStarted 2024-09-01

Plain-language summary

This study compares the effectiveness and safety of two different intralesional treatments for cutaneous warts: a combination of furosemide and digoxin versus polidocanol.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients over 18 years of age with single or multiple cutaneous warts. Exclusion Criteria: * History of allergies to the study medications, known cardiac or renal disease, hypertension, pregnancy or lactation, and any signs of systemic or local infection.

What they're measuring

Complete Clinical Response

Timeframe: Up to 8 weeks

Trial details

NCT IDNCT07307131

SponsorBenha University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-01

View on ClinicalTrials.gov More Cutaneous Warts trials